ALACHUA, Fla., Nov. 21, 2016 (GLOBE NEWSWIRE) — AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced the commercial release and first clinical implant of Avive™ Soft Tissue Membrane. Avive™ Soft Tissue Membrane… Read More
AxoGen, Inc. announces commercial release and first clinical implant of Avive™ Soft Tissue Membrane
